secwatch.observer — SEC 8-K summary
======================================

Issuer:     CODEXIS, INC. (CDXS)
CIK:        0001200375
Form:       8-K/A
Filed at:   2023-11-03T23:59:59+00:00
Accession:  0001193125-23-270422
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 2.05, 2.06
LLM model:  deepseek-v4-flash:cloud@v2

Codexis revises restructuring costs; records $9.2M asset impairment on facility
-------------------------------------------------------------------------------

- Workforce reduction of ~25% completed by Sept 30, 2023; actual severance costs $3.1M vs. expected $2.9M.
- Non-cash goodwill impairment of $0.8M from discontinuing Biotherapeutics programs.
- Non-cash asset impairment of $9.2M related to San Carlos facility previously assigned to Vaxcyte.
- Operations streamlined by exiting Biotherapeutics development and consolidating to headquarters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/0001193125-23-270422-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/d490820d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-270422

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer